H
35.56
1.06 (3.07%)
| 前收盘价格 | 34.50 |
| 收盘价格 | 34.53 |
| 成交量 | 591,923 |
| 平均成交量 (3个月) | 712,131 |
| 市值 | 2,042,008,192 |
| 市盈率 (P/E TTM) | 13.57 |
| 预期市盈率 (P/E Forward) | 8.33 |
| 价格/销量 (P/S) | 2.40 |
| 股市价格/股市净资产 (P/B) | 2.58 |
| 52周波幅 | |
| 利润日期 | 4 Aug 2025 - 8 Aug 2025 |
| 营业毛利率 | 20.36% |
| 营业利益率 (TTM) | 27.69% |
| 稀释每股收益 (EPS TTM) | 2.51 |
| 季度收入增长率 (YOY) | 19.50% |
| 季度盈利增长率 (YOY) | 85.90% |
| 总债务/股东权益 (D/E MRQ) | 27.52% |
| 流动比率 (MRQ) | 3.31 |
| 营业现金流 (OCF TTM) | 219.82 M |
| 杠杆自由现金流 (LFCF TTM) | 143.91 M |
| 资产报酬率 (ROA TTM) | 13.17% |
| 股东权益报酬率 (ROE TTM) | 25.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Harmony Biosciences Holdings, I | 看跌 | 混合的 |
AIStockmoo 评分
-0.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | -3.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.25 |
|
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.63% |
| 机构持股比例 | 98.14% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 70.00 (HC Wainwright & Co., 96.85%) | 购买 |
| 中 | 49.00 (37.80%) | |
| 低 | 48.00 (Mizuho, 34.98%) | 购买 |
| 48.00 (UBS, 34.98%) | 购买 | |
| 平均值 | 55.20 (55.23%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 32.14 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Oppenheimer | 02 Jun 2025 | 61.00 (71.54%) | 购买 | 35.56 |
| Mizuho | 15 May 2025 | 48.00 (34.98%) | 购买 | 34.23 |
| 18 Mar 2025 | 44.00 (23.73%) | 购买 | 34.78 | |
| Needham | 07 May 2025 | 49.00 (37.80%) | 购买 | 33.44 |
| 06 May 2025 | 49.00 (37.80%) | 购买 | 32.05 | |
| UBS | 28 Apr 2025 | 48.00 (34.98%) | 购买 | 29.36 |
| HC Wainwright & Co. | 08 Apr 2025 | 70.00 (96.85%) | 购买 | 28.13 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合